Found 70 matching trials
A Study for Post op Inflammation After Cataract Surgery
PHASE4This is a randomized, controlled study to assess the safety and effectivene...
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
PHASE4The purpose of this study is to compare the ability of two different topica...
Location
Bucci Laser Vision Institute and Ambulatory Surgery Center
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
PHASE4To compare bromfenac 0.09% and ketorolac 0.4% when used concomitantly with ...
Location
Florida Eye Microsurgical Institute
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
PHASE3The primary objective of this study was to investigate the efficacy of brom...
Location
Harold A Helms, MD
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
PHASE3The primary objective of this study is to investigate the efficacy and safe...
Location
ISTA Pharmaceuticals, Inc.
Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration
PHASE2This open-label, randomized, Phase II research study will look to see wheth...
Location
Casey Eye Institute at Oregon Health & Science University
A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%
PHASE4This is a post-approval, open-label, randomized, self-controlled prospectiv...
Location
Harvard Eye Associates
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
PHASE4This is a single-center, randomized, investigator-masked, parallel group, a...
Location
Multiple Locations
PRevention of Macular EDema After Cataract Surgery
PHASE3Cystoid macular edema (CME) is a common cause of vision loss after cataract...
Location
Vienna Institute for Research in Ocular Surgery, Hanusch Krankenhaus
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
PHASE3Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery...
Location
ISTA Pharmaceuticals, Inc.